GSK gets FDA approval for hepatitis B drug that offers functional cure
The approval of GSK and Ionis’ chronic hepatitis B drug bepirovirsen came early, setting it up to eventually reach blockbuster status. But the FDA gave the drug, now branded Hibsago, a
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.